1 O n c o l o Together for y LOncologia insieme per L*Aquila G Bruera, D Di Giacomo & E Ricevuto Medical Oncology Department Experimental.
New Strategies on Horizon Tony Mok MD Dept of Clinical Oncology The Chinse University of Hong Kong.
Extending life for women with HER2-positive MBC Andreas Makris Mount Vernon Hospital Middlesex, UK.
Novel Agents for Indolent Lymphoma and Mantle Cell Lymphoma Stephen Ansell, MD, PhD Mayo Clinic.
Optimizing Treatment for Her 2 Positive Metastatic Breast Cancer Patients Sunil Verma MD, MSEd, FRCPC Medical Oncologist Chair, Breast Medical Oncology.
Results of a Randomized Phase III Trial (MPACT) of Weekly nab-Paclitaxel Plus Gemcitabine vs Gemcitabine Alone for Patients With Metastatic Adenocarcinoma.
Novel Agents for Indolent L ymphoma and Mantle Cell Lymphoma
New Strategies on Horizon
Harnessing the Power of the Host Immune System to Fight Cancer Robert Kastelein Immuno-Oncology Discovery Texas FreshAIR Conference 2014 Houston October.
